DayOne essentially comprises three functions:
- a community of experts who meet regularly for workshop events to share new concepts and ideas
- a lab in which these project ideas can mature into prototypes
- an open innovation conference that helps to get project ideas up and running on a concrete path
In the second part of the launch event, the invited guests had the opportunity to discuss the objective and purpose of the initiative. The discussion was led by a panel of prominent experts in their field: Domenico Scala, President, BaselArea.swiss; Dr. Tim Jaeger, Global Head of Diagnostics Information Solutions at Roche Diagnostics, Roche; Dr. Bram Stieltjes, Research Group Leader University Hospital Basel and Entrepreneur; Dr. Othmar Pfannes, CEO, Genedata; and Dr. Falko Schlottig, Director of the School of Life Sciences, University of Applied Sciences and Arts, Northwestern Switzerland (FHNW).
There was unanimity on the question of urgency: the technology is there, they agreed, but what needs to be improved is the collaboration between the disciplines and stakeholders in the healthcare sector. There was also no doubt that the Basel region offers the right breeding ground for this. Deficits were found, however, in the area of ICT expertise and also in the willingness to invest. In this respect, DayOne was certainly expected to be capable of playing a certain pacemaker role. But, as Domenico Scala said in his closing words, very much clearer markers must also be laid down to expand the Basel region in desired direction. In particular, he said, there is a need to seek expansion in the direction of Bioinformatics and Precision Medicine at university level and more venture capital from institutional investors.